HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lady Gaga Fame To Debut In September With “First-Ever” Black Juice

This article was originally published in The Rose Sheet

Executive Summary

Lady Gaga’s first fragrance – dubbed Fame – features patent-pending fluid technology that makes the black juice spray clear, Coty Inc. says June 14. The scent’s structure deviates from the traditional pyramid, with ingredients interacting without hierarchy.

You may also be interested in...



Coty Aims To Hit High Note With Katy Perry Fragrance

Coty Inc. and Katy Perry combine the mega-hit recording artist’s strength, confidence, humor and artistic vision in launching her Killer Queen fragrance and associated marketing campaign.

Coty Projects Slight Q1 Decline, Citing “Drastic Drop” In Nail Segment

Coty is holding off on full-year projections until it gains visibility into the back-to-school and Christmas seasons, but expects first-quarter revenues to be down, largely due to a significant decline in nail-care consumption. The newly public firm looks to offset retailer destocking with innovations across its portfolio, previewed during its fiscal 2013 fourth-quarter and year-end earnings call.

Coty Growth Driven By On-Trend New Products

Marketer of Sally Hansen and Rimmel attributes its strong growth in 2011 to staying ahead of trends in the marketplace. Coty Inc. expects more of the same for 2012, along with a highly anticipated Lady Gaga scent, expected to be the “biggest fragrance launch this year.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel